| Authors | Francis Giles, David Rizzieri, Farhad Ravandi, Ronan Swords, Tove Flem Jacobsen, Susan O'Brien |
| Journal | Leukemia research
(Leuk Res)
Vol. 36
Issue 4
Pg. e71-3
(Apr 2012)
ISSN: 1873-5835 [Electronic] England |
| PMID | 22226018
(Publication Type: Clinical Trial, Phase I, Letter, Multicenter Study)
|
| Chemical References |
- Cytarabine
- 5'-oleoyl cytarabine
- Idarubicin
|
| Topics |
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(pharmacokinetics, therapeutic use)
- Area Under Curve
- Cytarabine
(administration & dosage, adverse effects, analogs & derivatives, pharmacokinetics)
- Female
- Half-Life
- Humans
- Idarubicin
(administration & dosage, adverse effects, pharmacokinetics)
- Leukemia, Myeloid, Acute
(drug therapy)
- Male
- Maximum Tolerated Dose
- Middle Aged
- Young Adult
|
